Product

Idursulfase

1 clinical trial

1 indication

Indication
MPS II
Clinical trial
A Phase III Study of JR-141 in Patients With Mucopolysaccharidosis II (STARLIGHT)
Status: Recruiting, Estimated PCD: 2026-01-31